Claims for Patent: 10,357,567

Summary for Patent: 10,357,567

Title:	Methods for photodynamic therapy
Abstract:	A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.
Inventor(s):	Lundahl; Scott (Lexington, MA), Guttadauro; Michael (Carlisle, MA)
Assignee:	DUSA Pharmaceuticals, Inc. (Wilmington, MA)
Application Number:	15/869,164
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,357,567
Patent Claims:	1. A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy, the method comprising: topically applying ALA to a treatment area to be treated with photodynamic therapy; after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area; and removing the low density polyethylene barrier within 3 hours and then applying light to the treatment area. 2. A method as set forth in claim 1, wherein the low density polyethylene barrier is removed from the treatment area within 3 hours and then blue light is applied to the treatment area for a 10 J/cm.sup.2 light dose. 3. The method of claim 1, wherein a maximum plasma concentration of ALA following application of the ALA is less than about 110 ng/mL. 4. A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy, the method comprising: topically applying ALA to a treatment area to be treated with photodynamic therapy; and after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area, wherein the treatment area is located on a hand or a forearm. 5. A method as set forth in claim 4, wherein the low density polyethylene barrier is removed from the treatment area and then red light is applied to the treatment area for a 10 to 75 J/cm.sup.2 light dose. 6. The method as set forth in claim 4, wherein the treatment area is a dorsal surface of the hand. 7. The method as set forth in claim 4, wherein the treatment area is a dorsal surface of the forearm. 8. A method of using 5-aminolevulinic acid (ALA) and a low density polyethylene barrier, comprising: contacting a treatment site with a composition comprising the ALA so as to wet the treatment site; following wetting of the treatment site, covering the wetted treatment site with the low density polyethylene barrier; removing the low density polyethylene barrier so as to expose the treatment site; and illuminating the exposed treatment site with an illuminator so as to deliver a 10 J/cm.sup.2 dose of blue light. 9. The method of claim 8, wherein the low density polyethylene barrier is removed no later than three hours after the treatment site is covered. 10. The method of claim 8, further comprising: positioning the treatment site between two inches and four inches from a surface of the illuminator.